Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Amylyx Pharmaceuticals, Inc.. A complete text table follows the diagram.
Neuroscience medicines and development programs target serious neurodegenerative disease.
Swipe to explore
Labels and displayed flow values are reported filing values or exact disclosed subtotals.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Total reported revenue | 1 | $43.8M | Reported filing total |
| Neuroscience medicines platform | 2 | $43.8M | Company-specific editorial view |
| From | To | Value |
|---|---|---|
| Total reported revenue | Neuroscience medicines platform | $43.8M |